SRDX stock forecast
Our latest prediction for Surmodics, Inc.'s stock price was made on the March 1, 2021 when the stock price was at 53.05$.
In the short term (2weeks), SRDX's stock price should underperform the market by -1.61%. During that period the price should oscillate between -7.15% and +5.41%.
In the medium term (3months), SRDX's stock price should underperform the market by -3.73%. During that period the price should oscillate between -24.04% and +14.04%.Get email alerts
Create a solid portfolio with SRDX
About Surmodics, Inc.
Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Surmodics is pursuing highly differentiated medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company's expertise in proprietary surface technologies, along with enhanced device design, development, and manufacturing capabilities. The Company mission remains to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com. The content of Surmodics' website is not part of this press release or part of any filings that the company makes with the SEC.
At the moment the company generates 107M USD in revenues.
On its last earning announcement, the company reported a profit of 0.52$ per share.
The book value per share is 8.14$
Three months stock forecastMarch 1, 2021
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|